To view or add a comment, sign in GLP1, Wegovy, has recently been FDA-approved for MASH patients with moderate-to-advanced fibrosis hot on the heels of last years approval of first-mover, Rezdifrra
albicans that is resistant to echinocandin antifungal drugs, and can enhance the therapeutic effect of echinocandin antifungal drugs (Puumala et al., 2025)
Melanotan II was a cyclic form with dramatically higher potency and non-selective activity at all melanocortin receptors
No Validated Epithalon Age-Reversal Test Commercial testing before and after Epithalon exposure cannot establish rejuvenation unless the test is validated, the change exceeds normal variation and a controlled comparator is included
Start with the five-minute intake form at tryshed.com to see whether you qualify
Medical guidelines, drug availability, insurance policies, and telehealth regulations change frequently